Treatment of postoperative gastric cancer with the Fuzheng Huoxue anticancer prescription

Table 2 Changes in hypercoagulatory parameters before and after treatment in the two groups (mean ± SD)

Groups		n	AT-III (mg/dl)	FA (%)	β-TG (ng/dl)
Treatment	Before	35	29.9 ± 7.9b	50.4 ± 24.4b	91.0 ± 25.9b
	After	35	38.8 ± 5.5d	102.6 ± 31.6d	62.3 ± 15.1bd
Control	Before	34	32.3 ± 7.2a	57.3 ± 24.6b	87.5 ± 34.2b
	After	34	30.9 ± 8.0b	64.6 ± 26.9b	67.0 ± 42.1bc
Healthy persons			36.4 ± 8.3 (59)	90.3 ± 24.3 (30)	25.0 ± 8.2 (103)

^aP < 0.05,

^bP < 0.01 as compared with healthy subjects;

^cP < 0.05,

^dP < 0.001 as compared with pretreatment. The number of individuals is shown in parentheses.